[HTML][HTML] Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD …
AD D'Urzo, SI Rennard, EM Kerwin, V Mergel… - Respiratory …, 2014 - Springer
Background Combining two long-acting bronchodilators with complementary mechanisms of
action may provide treatment benefits to patients with chronic obstructive pulmonary disease …
action may provide treatment benefits to patients with chronic obstructive pulmonary disease …
Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study.
AD D'Urzo, SI Rennard, EM Kerwin… - Respiratory …, 2014 - search.ebscohost.com
Background: Combining two long-acting bronchodilators with complementary mechanisms
of action may provide treatment benefits to patients with chronic obstructive pulmonary …
of action may provide treatment benefits to patients with chronic obstructive pulmonary …
Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: The 24-week, randomized, placebo-controlled AUGMENT COPD study
AUGMENT COPD study investigators - Respiratory Research, 2014 - experts.nebraska.edu
Background: Combining two long-acting bronchodilators with complementary mechanisms
of action may provide treatment benefits to patients with chronic obstructive pulmonary …
of action may provide treatment benefits to patients with chronic obstructive pulmonary …
Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
AD D'Urzo, SI Rennard, EM Kerwin, V Mergel… - Respiratory …, 2014 - hero.epa.gov
Background: Combining two long-acting bronchodilators with complementary mechanisms
of action may provide treatment benefits to patients with chronic obstructive pulmonary …
of action may provide treatment benefits to patients with chronic obstructive pulmonary …
[PDF][PDF] Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
AD D'Urzo, SI Rennard, EM Kerwin, V Mergel… - 2014 - cyberleninka.org
Background: Combining two long-acting bronchodilators with complementary mechanisms
of action may provide treatment benefits to patients with chronic obstructive pulmonary …
of action may provide treatment benefits to patients with chronic obstructive pulmonary …
[引用][C] Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
AD D'Urzo, SI Rennard, EM Kerwin, V Mergel… - Respiratory …, 2014 - cir.nii.ac.jp
Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the
24-week, randomized, placebo-controlled AUGMENT COPD study | CiNii Research CiNii 国立 …
24-week, randomized, placebo-controlled AUGMENT COPD study | CiNii Research CiNii 国立 …
Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
AD D'Urzo, SI Rennard, EM Kerwin, V Mergel… - Respiratory …, 2014 - infona.pl
Background Combining two long-acting bronchodilators with complementary mechanisms of
action may provide treatment benefits to patients with chronic obstructive pulmonary disease …
action may provide treatment benefits to patients with chronic obstructive pulmonary disease …
[HTML][HTML] Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD …
AD D'Urzo, SI Rennard, EM Kerwin, V Mergel… - Respiratory …, 2014 - ncbi.nlm.nih.gov
Background Combining two long-acting bronchodilators with complementary mechanisms of
action may provide treatment benefits to patients with chronic obstructive pulmonary disease …
action may provide treatment benefits to patients with chronic obstructive pulmonary disease …
Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
AD D'Urzo, SI Rennard, EM Kerwin, V Mergel… - Respiratory …, 2014 - go.gale.com
Background In patients with chronic obstructive pulmonary disease (COPD), combining
bronchodilators with complementary mechanisms of action has the potential to increase …
bronchodilators with complementary mechanisms of action has the potential to increase …
Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study.
AD D'Urzo, SI Rennard, EM Kerwin, V Mergel… - Respiratory …, 2014 - europepmc.org
Background Combining two long-acting bronchodilators with complementary mechanisms of
action may provide treatment benefits to patients with chronic obstructive pulmonary disease …
action may provide treatment benefits to patients with chronic obstructive pulmonary disease …